Literature DB >> 83119

Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis.

M L Cuzner, A N Davison, P Rudge.   

Abstract

Upon stimulation by immune complexes, the polymorphonuclear (PMN) blood secretes lysosomal hydrolases, including neutral proteinase, which is concentrated in the PMN cell. Neutral and acid proteinase activity were increased and decreased, respectively, in the circulating white cells of patients with multiple sclerosis during an exacerbation of the disease, but there was no correlation with serum immune complex levels. Neutral proteolytic activity in the cellular fraction of the cerebrospinal fluid was also found to be elevated in acute multiple sclerosis, as monitored by digestion of myelin basic protein.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 83119     DOI: 10.1002/ana.410040409

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

Review 1.  The role of TNFalpha and lymphotoxin in demyelinating disease.

Authors:  C Lock; J Oksenberg; L Steinman
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Differences in susceptibility of MBP charge isomers to digestion by stromelysin-1 (MMP-3) and release of an immunodominant epitope.

Authors:  Cheryl A D'Souza; Mario A Moscarello
Journal:  Neurochem Res       Date:  2006-07-27       Impact factor: 3.996

3.  The need for a new strategy for the treatment of multiple sclerosis.

Authors:  A N Davison
Journal:  J Neurol       Date:  1988-07       Impact factor: 4.849

Review 4.  Proteinases in inflammatory demyelinating disease.

Authors:  C T Bever; J N Whitaker
Journal:  Springer Semin Immunopathol       Date:  1985

5.  Myelin basic protein in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.

Authors:  A Biber; D Englert; D Dommasch; K Hempel
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

6.  Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.

Authors:  A Petzold; M J Eikelenboom; G Keir; D Grant; R H C Lazeron; C H Polman; B M J Uitdehaag; E J Thompson; G Giovannoni
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-02       Impact factor: 10.154

7.  Loss of lysosomal neutral proteinase from leucocytes induced by the action of multiple sclerosis-specific brain antigens.

Authors:  S C Rastogi; J Clausen
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

8.  The value of the measurement of cerebrospinal fluid levels of lysozyme in the diagnosis of neurological disease.

Authors:  G Firth; J Rees; R O McKeran
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-07       Impact factor: 10.154

9.  Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine.

Authors:  K Norga; L Paemen; S Masure; C Dillen; H Heremans; A Billiau; H Carton; L Cuzner; T Olsson; J Van Damme
Journal:  Inflamm Res       Date:  1995-12       Impact factor: 4.575

10.  Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790.

Authors:  A K Hewson; T Smith; J P Leonard; M L Cuzner
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.